furosemide has been researched along with Diabetes Mellitus, Adult-Onset in 30 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the factors that determine the blood pressure response to enalapril and nifedipine monotherapy in the treatment of hypertension associated with non-insulin-dependent diabetes mellitus (NIDDM)." | 9.08 | Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM. ( Chan, JC; Cheung, CK; Cockram, CS; Law, LK; Nicholls, MG; Swaminathan, R, 1995) |
| "A 54-year-old Asian woman weighing 77 kg developed massive bilateral pleural effusion after receiving pioglitazone (30 mg QD) in combination with glimepiride 2 mg BID and metformin 500 mg TID." | 7.74 | Massive bilateral pleural effusion associated with use of pioglitazone. ( Chen, HH; Chen, YC; Chen, YW; Wu, CJ, 2008) |
| "Our previous study demonstrated increased sodium (Na+) influx into ouabain-treated erythrocytes in diabetic patients with hypertension." | 7.67 | Increased furosemide-sensitive sodium influx into erythrocytes in non-insulin-dependent diabetes mellitus associated with hypertension. ( Chimori, K; Dodo, S; Goi, R; Goto, S; Hayashi, H; Izai, M; Miura, K; Miyazaki, S; Yasuda, K, 1989) |
| "31% of patients had type 2 diabetes mellitus (DM2)." | 7.30 | The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study. ( Andreev, DA; Charaya, KV; Dimchishina, AS; Kusova, ZR; Mesitskaya, DF; Nikiforova, TV; Novikova, NA; Schekochikhin, DIY; Shkliarov, AM; Soboleva, TV, 2023) |
| "31% of patients had type 2 diabetes mellitus (DM2)." | 7.30 | The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study. ( Andreev, DA; Charaya, KV; Dimchishina, AS; Kusova, ZR; Mesitskaya, DF; Nikiforova, TV; Novikova, NA; Schekochikhin, DY; Shkliarov, AM; Soboleva, TV, 2023) |
| "To examine the factors that determine the blood pressure response to enalapril and nifedipine monotherapy in the treatment of hypertension associated with non-insulin-dependent diabetes mellitus (NIDDM)." | 5.08 | Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM. ( Chan, JC; Cheung, CK; Cockram, CS; Law, LK; Nicholls, MG; Swaminathan, R, 1995) |
| "A 54-year-old Asian woman weighing 77 kg developed massive bilateral pleural effusion after receiving pioglitazone (30 mg QD) in combination with glimepiride 2 mg BID and metformin 500 mg TID." | 3.74 | Massive bilateral pleural effusion associated with use of pioglitazone. ( Chen, HH; Chen, YC; Chen, YW; Wu, CJ, 2008) |
| " Due to the osteomyelitis, the patient was started on a regimen of intravenous vancomycin as well as furosemide tablets (Fusid) for pedal edema." | 3.73 | [Acute generalized exanthematous pustulosis (AGEP) following intake of furosemide]. ( Cagnano, E; Davidovici, BB; Halevy, S; Naveh, HP, 2006) |
| "A 66-year-old hypertensive diabetic patient with latent hypoaldosteronism and mild renal failure was treated by adding enalapril, an angiotensin converting enzyme inhibitor, to the furosemide and nifedipine regimen because of an insufficient antihypertensive response for 1 month." | 3.69 | Reversible hyperkalemia during antihypertensive therapy in a hypertensive diabetic patient with latent hypoaldosteronism and mild renal failure. ( Azukizawa, S; Kaneko, M; Kigoshi, T; Matsui, A; Morimoto, S; Nakano, S; Uchida, K, 1994) |
| "Our previous study demonstrated increased sodium (Na+) influx into ouabain-treated erythrocytes in diabetic patients with hypertension." | 3.67 | Increased furosemide-sensitive sodium influx into erythrocytes in non-insulin-dependent diabetes mellitus associated with hypertension. ( Chimori, K; Dodo, S; Goi, R; Goto, S; Hayashi, H; Izai, M; Miura, K; Miyazaki, S; Yasuda, K, 1989) |
| "31% of patients had type 2 diabetes mellitus (DM2)." | 3.30 | The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study. ( Andreev, DA; Charaya, KV; Dimchishina, AS; Kusova, ZR; Mesitskaya, DF; Nikiforova, TV; Novikova, NA; Schekochikhin, DIY; Shkliarov, AM; Soboleva, TV, 2023) |
| "31% of patients had type 2 diabetes mellitus (DM2)." | 3.30 | The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study. ( Andreev, DA; Charaya, KV; Dimchishina, AS; Kusova, ZR; Mesitskaya, DF; Nikiforova, TV; Novikova, NA; Schekochikhin, DY; Shkliarov, AM; Soboleva, TV, 2023) |
| "Of 381 patients who had type 2 diabetes and were on treatment with sulfonylurea or sulfonylurea plus metformin, 260 (63% male, 37% female) showed evidence of volume expansion as defined by an absolute reduction in hematocrit (Hct) of > or =0." | 2.72 | Effect of various diuretic treatments on rosiglitazone-induced fluid retention. ( Buckingham, R; Karalliedde, J; Lorand, D; Starkie, M; Stewart, M; Viberti, G, 2006) |
| " This patient's case highlights the need of further studies evaluating efficacy of repeated dosing of CCP." | 1.62 | Sequential dosing of convalescent COVID-19 plasma with significant temporal clinical improvements in a persistently SARS-COV-2 positive patient. ( Bloch, EM; Chua, F; Goel, R; Katz, LM; Mirihagalle, N; Parajuli, P; Prakash, V; Saha, D; Shah, A; Sundareshan, V; Tobian, AAR; Waqar, S, 2021) |
| "In dapagliflozin-treated NASH mice, hypoglycemia was not identified during 24-hour casual blood glucose monitoring." | 1.56 | Effects of Sodium-Glucose Cotransporter 2 Inhibition on Glucose Metabolism, Liver Function, Ascites, and Hemodynamics in a Mouse Model of Nonalcoholic Steatohepatitis and Type 2 Diabetes. ( Nakamoto, K; Tsubakimoto, M; Yabiku, K, 2020) |
| "Insulin oedema is an uncommon cause of oedema in patients recently commenced on insulin therapy." | 1.51 | Severe oedema in a patient with diabetes. ( Amrapala, A; Chowdhury, TA, 2019) |
| "Type 2 diabetic kidney disease (DKD) is frequently accompanied by uncontrollable hypertension due to the sodium sensitivity inherent in DKD and to diuretic-resistant edema." | 1.42 | Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease. ( Hirai, K; Hoshino, T; Ito, K; Kaku, Y; Miyazawa, H; Mori, H; Ookawara, S; Tabei, K; Ueda, Y; Yoshida, I, 2015) |
| "Acute myocardial infarction is a rare complication of dobutamine stress echocardiography." | 1.39 | [Acute myocardial infarction complicated by acute pulmonary oedema and cardiogenic collapse during dobutamine stress echocardiography]. ( Diack, B; Diagne-Sow, D; Dioum, M; Kagambega, LJ; Kane, A; Kane, M; Mbaye, A; Yameogo, NV, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (13.33) | 18.7374 |
| 1990's | 4 (13.33) | 18.2507 |
| 2000's | 6 (20.00) | 29.6817 |
| 2010's | 7 (23.33) | 24.3611 |
| 2020's | 9 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiuchi, Y | 2 |
| Matsue, Y | 2 |
| Nogi, K | 2 |
| Onitsuka, K | 2 |
| Okumura, T | 2 |
| Hoshino, M | 2 |
| Shibata, T | 2 |
| Nitta, D | 2 |
| Yoshida, K | 2 |
| Sato, S | 2 |
| Damman, K | 2 |
| Voors, AA | 2 |
| Kitai, T | 2 |
| Patil, T | 2 |
| Halsey, E | 2 |
| Kaur, A | 2 |
| Minchak, J | 2 |
| Hobson, J | 2 |
| Eppes, D | 2 |
| Charaya, KV | 2 |
| Schekochikhin, DIY | 1 |
| Nikiforova, TV | 2 |
| Dimchishina, AS | 2 |
| Soboleva, TV | 2 |
| Shkliarov, AM | 2 |
| Kusova, ZR | 2 |
| Mesitskaya, DF | 2 |
| Novikova, NA | 2 |
| Andreev, DA | 2 |
| Schekochikhin, DY | 1 |
| Patoulias, D | 1 |
| Papadopoulos, C | 1 |
| Zografou, I | 1 |
| Doumas, M | 1 |
| Cunha, FM | 1 |
| Bettencourt, P | 1 |
| Lourenço, P | 1 |
| Yabiku, K | 1 |
| Nakamoto, K | 1 |
| Tsubakimoto, M | 1 |
| Mirihagalle, N | 1 |
| Parajuli, P | 1 |
| Sundareshan, V | 1 |
| Saha, D | 1 |
| Shah, A | 1 |
| Chua, F | 1 |
| Waqar, S | 1 |
| Prakash, V | 1 |
| Tobian, AAR | 1 |
| Bloch, EM | 1 |
| Katz, LM | 1 |
| Goel, R | 1 |
| Amrapala, A | 1 |
| Chowdhury, TA | 1 |
| Yameogo, NV | 1 |
| Mbaye, A | 1 |
| Kagambega, LJ | 1 |
| Dioum, M | 1 |
| Diagne-Sow, D | 1 |
| Kane, M | 1 |
| Diack, B | 1 |
| Kane, A | 1 |
| Hoshino, T | 1 |
| Ookawara, S | 1 |
| Miyazawa, H | 1 |
| Ito, K | 1 |
| Ueda, Y | 1 |
| Kaku, Y | 1 |
| Hirai, K | 1 |
| Mori, H | 1 |
| Yoshida, I | 1 |
| Tabei, K | 1 |
| Chen, YW | 1 |
| Chen, YC | 1 |
| Wu, CJ | 1 |
| Chen, HH | 1 |
| Hernández, LM | 1 |
| Salinas, RM | 1 |
| Cabrera, MS | 1 |
| Acosta, GP | 1 |
| Henríquez, MS | 1 |
| Quintana, PP | 1 |
| Díaz, JG | 1 |
| Manrique Franco, K | 1 |
| López-Mezquita Torres, E | 1 |
| Sánchez García, L | 1 |
| Aragón Valera, C | 1 |
| Sanchez-Vilar Burdiel, O | 1 |
| Rosario, M | 1 |
| Song, SX | 1 |
| McCullough, LD | 1 |
| Pruijm, M | 1 |
| Hofmann, L | 1 |
| Zanchi, A | 1 |
| Maillard, M | 1 |
| Forni, V | 1 |
| Muller, ME | 1 |
| Wuerzner, G | 1 |
| Vogt, B | 1 |
| Stuber, M | 1 |
| Burnier, M | 1 |
| Ciardella, AP | 1 |
| Davidovici, BB | 1 |
| Naveh, HP | 1 |
| Cagnano, E | 1 |
| Halevy, S | 1 |
| Karalliedde, J | 1 |
| Buckingham, R | 1 |
| Starkie, M | 1 |
| Lorand, D | 1 |
| Stewart, M | 1 |
| Viberti, G | 1 |
| Chan, JC | 1 |
| Nicholls, MG | 1 |
| Cheung, CK | 1 |
| Law, LK | 1 |
| Swaminathan, R | 1 |
| Cockram, CS | 1 |
| Uchida, K | 2 |
| Azukizawa, S | 1 |
| Nakano, S | 1 |
| Kaneko, M | 1 |
| Kigoshi, T | 2 |
| Morimoto, S | 2 |
| Matsui, A | 1 |
| Lièvre, M | 1 |
| Marre, M | 1 |
| Tippins, RB | 1 |
| Torres, WE | 1 |
| Baumgartner, BR | 1 |
| Baumgarten, DA | 1 |
| Malvezzi, P | 1 |
| Rampino, T | 1 |
| Dal Canton, A | 1 |
| Lamey, PJ | 1 |
| Gibson, J | 1 |
| Barclay, SC | 1 |
| Miller, S | 1 |
| Iwasaki, R | 1 |
| Chimori, K | 1 |
| Miyazaki, S | 1 |
| Goi, R | 1 |
| Dodo, S | 1 |
| Hayashi, H | 1 |
| Izai, M | 1 |
| Goto, S | 1 |
| Yasuda, K | 1 |
| Miura, K | 1 |
| Osei, K | 1 |
| Falko, JM | 1 |
| Matthews, DM | 1 |
| Wathen, CG | 1 |
| Bell, D | 1 |
| Collier, A | 1 |
| Roulston, JE | 1 |
| Clarke, BF | 1 |
| Muir, AL | 1 |
| Kikuchi, H | 1 |
| Toyoda, N | 1 |
| Ezawa, S | 1 |
| Yoshida, S | 1 |
| Hibino, Y | 1 |
| Sunaga, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Acute Hyperglycemia on Renal Tissue Oxygenation as Measured By BOLD-MRI in Individuals With Impaired Glucose Tolerance and Controls[NCT02346149] | Early Phase 1 | 19 participants (Actual) | Interventional | 2015-06-30 | Completed | ||
| A Randomised Study Examining the Effect of Different Diuretics on Fluid Balance in Diabetics Treated With Avandia[NCT00306696] | Phase 4 | 388 participants (Actual) | Interventional | 2002-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for furosemide and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Hypercalcemia worsened by the use of furosemide in a patient suffering from allopurinol-induced granulomatous hepatitis.
Topics: Allopurinol; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Type 2; Diuretics; Fever; Fu | 2010 |
7 trials available for furosemide and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; | 2023 |
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; | 2023 |
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; | 2023 |
Early treatment with a sodium-glucose co-transporter 2 inhibitor in high-risk patients with acute heart failure: Rationale for and design of the EMPA-AHF trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Furosemide; Glucose; Heart Failure; Humans; Sodium; | 2023 |
The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Furosemide; Heart F | 2023 |
The use of Dapagliflozin in Acute Decompensated Heart Failure: Results of the Randomized Study.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Female; Furosemide; Heart F | 2023 |
Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes.
Topics: Aged; Angiotensin Receptor Antagonists; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Furos | 2013 |
Effect of various diuretic treatments on rosiglitazone-induced fluid retention.
Topics: Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Ede | 2006 |
Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
Topics: Albuminuria; Aldosterone; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Glucose; Blood P | 1995 |
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus, Type 2; Furose | 1999 |
22 other studies available for furosemide and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Gly | 2023 |
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Gly | 2023 |
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Gly | 2023 |
CHAnges in Diuretic Medication Prescribing and Surrogate Laboratory Parameters After Initiating EmpagliflOziN in Veterans (CHAMPION Cohort Study).
Topics: Benzhydryl Compounds; Cohort Studies; Diabetes Mellitus, Type 2; Diuretics; Furosemide; Glucose; Gly | 2023 |
Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for sodium-glucose cotransporter-2 inhibitors?
Topics: Diabetes Mellitus, Type 2; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter In | 2020 |
Response to letter: 'Acute heart failure, type 2 diabetes and loop diuretic use: any adjunct role for SGLT-2 inhibitors?'
Topics: Diabetes Mellitus, Type 2; Furosemide; Heart Failure; Humans; Sodium Potassium Chloride Symporter In | 2020 |
Effects of Sodium-Glucose Cotransporter 2 Inhibition on Glucose Metabolism, Liver Function, Ascites, and Hemodynamics in a Mouse Model of Nonalcoholic Steatohepatitis and Type 2 Diabetes.
Topics: Animals; Ascites; Benzhydryl Compounds; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Diseas | 2020 |
Sequential dosing of convalescent COVID-19 plasma with significant temporal clinical improvements in a persistently SARS-COV-2 positive patient.
Topics: Anti-Bacterial Agents; Combined Modality Therapy; COVID-19; COVID-19 Serotherapy; Diabetes Mellitus, | 2021 |
Severe oedema in a patient with diabetes.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Diagnosis, Differential; Diuretics; Edema; | 2019 |
[Acute myocardial infarction complicated by acute pulmonary oedema and cardiogenic collapse during dobutamine stress echocardiography].
Topics: Diabetes Mellitus, Type 2; Diuretics; Echocardiography, Stress; Furosemide; Heart Failure; Humans; M | 2013 |
Renoprotective effects of thiazides combined with loop diuretics in patients with type 2 diabetic kidney disease.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diabeti | 2015 |
Massive bilateral pleural effusion associated with use of pioglitazone.
Topics: Diabetes Mellitus, Type 2; Diuretics; Female; Furosemide; Humans; Hypoglycemic Agents; Middle Aged; | 2008 |
[Superior vena cava syndrome due to intrathoracic goiter].
Topics: Aged; Albumins; Atrial Fibrillation; Blood Vessel Prosthesis Implantation; Combined Modality Therapy | 2011 |
An unusual case of stroke.
Topics: Antihypertensive Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diuretics; Female; Furo | 2012 |
Partial resolution of diabetic macular oedema after systemic treatment with furosemide.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diuretics; Female; Furosemide; Humans; Macul | 2004 |
[Acute generalized exanthematous pustulosis (AGEP) following intake of furosemide].
Topics: Diabetes Mellitus, Type 2; Diuretics; Edema; Female; Furosemide; Humans; Middle Aged; Osteomyelitis; | 2006 |
Reversible hyperkalemia during antihypertensive therapy in a hypertensive diabetic patient with latent hypoaldosteronism and mild renal failure.
Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Furos | 1994 |
Are screening serum creatinine levels necessary prior to outpatient CT examinations?
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ambulatory Care; Antineoplastic Combined Ch | 2000 |
Lunch-related polyuria.
Topics: Aged; Diabetes Mellitus, Type 2; Diet; Furosemide; Humans; Male; Polyuria | 2002 |
Grinspan's syndrome: a drug-induced phenomenon?
Topics: Aged; Aged, 80 and over; Atenolol; Bendroflumethiazide; Chlorpropamide; Diabetes Mellitus, Type 2; D | 1990 |
Plasma 18-hydroxycorticosterone and aldosterone responses to angiotensin II and corticotropin in diabetic patients with hyporeninemic and normoreninemic hypoaldosteronism.
Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Corticosterone; | 1989 |
Increased furosemide-sensitive sodium influx into erythrocytes in non-insulin-dependent diabetes mellitus associated with hypertension.
Topics: Adolescent; Adult; Aged; Diabetes Mellitus, Type 2; Erythrocytes; Female; Furosemide; Humans; Hypert | 1989 |
Chronic hyponatremia associated with diabetic amyotrophy.
Topics: Atrophy; Body Weight; Demeclocycline; Diabetes Mellitus, Type 2; Electrolytes; Furosemide; Humans; H | 1986 |
The use of captopril and captopril plus frusemide as antihypertensive agents in non-insulin dependent diabetes.
Topics: Blood Glucose; Blood Pressure; Captopril; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fema | 1987 |
Effects of hot‑water extracts from 26 herbs on α‑glucosidase activity.
Topics: alpha-Glucosidases; Animals; Arctostaphylos; Aspalathus; Diabetes Mellitus, Type 2; Disease Models, | 2020 |